Calm Waters Partnership
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: Calm Waters Partnership stock price vs CI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CI's multiple
Needs EPS (TTM), CI P/E.
Implied fair value · at Calm Waters Partnership's multiple
Needs Calm Waters Partnership P/E.
Engine logicCalm Waters Partnershipvalued onCI’smultiple
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Calm Waters Partnership Latest annual filing · CI FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 70% equity / 30% debt · EV / Revenue 0.35x · EV / EBITDA 8.96x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CALM WATERS PARTNERSHIP · implied price per share
Reporting currency could not be verified.
The Cigna Group · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Calm Waters Partnership · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
—
0.75x
Net debt / EBITDA
Leverage against operating earnings
—
2.09x
Cash and equivalents
Liquid reserves on the balance sheet
—
$8.73B
Total debt
Interest-bearing obligations outstanding
—
$31.46B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
UNITEDHEALTH GROUP INC
Calm Waters Partnership vs UNH
CVS HEALTH Corp
Calm Waters Partnership vs CVS
HUMANA INC
Calm Waters Partnership vs HUM
CENTENE CORP
Calm Waters Partnership vs CNC
WEST PHARMACEUTICAL SERVICES INC
Calm Waters Partnership vs WST
BAXTER INTERNATIONAL INC
Calm Waters Partnership vs BAX
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.